gramedica Latest News

Turn-key Solution for Nail and Skin Rejuvenation will be Available Only through a Physician’s Office.

Revolutionary Type II Extra-Osseous TaloTarsal Stabilization device celebrates 8 years of helping patients throughout the world end their suffering from the effects TaloTarsal Displacement.

Top Chinese surgeon travels to observe the HyProCure® procedure firsthand from leading U.S. foot and ankle surgeons.

Global orthopedic medical device company, GraMedica®, supports podiatric students in their efforts to raise money to help the Yucatan Crippled Children’s Project.

After 12 year old aspiring singer underwent the HyProCure® Extra-Osseous TaloTarsal Stabilization (EOTTS) procedure, she now has “normal looking feet” with no pain.

Recent article published by the International Federation of Podiatrists uses evidenced based medicine to support claim regarding EOTTS with HyProCure®

Turn-key Solution for Nail and Skin Rejuvenation will be Available Only through a Physician’s Office.

Michael E. Graham, DPM, FACFAS, FAENS, lectured on innovations in foot and ankle surgery at the 33rd Annual International Congress of the Dominican Society of Orthopedics and Traumatology.

Revolutionary Type II Extra-Osseous TaloTarsal Stabilization device celebrates 8 years of helping patients throughout the world end their suffering from the effects TaloTarsal Displacement.

The Graham International Implant Institute® honors Dr. Jian Zhong Zhang with prestigious award.

Specialists in attendance at China’s leading Foot and Ankle Symposium gained valuable education on the Extra-Osseous TaloTarsal Stabilization Procedure.

In a recent journey throughout China, innovator of the life changing HyProCure® procedure took time to educate surgeons, meet with patients and share his skills.

Pioneer in TaloTarsal Stabilization Speaks on the Biomechanics of the Talotarsal Mechanism.

Celebrating 100 Years, The National was a great success with lectures on the latest advances in the podiatric field, one of a kind festivities and a sold out exhibit hall.

Philip Bresnahan, DPM, FACFAS, provides insight into literature and studies that show the benefits of extra-osseous talotarsal stabilization (EOTTS) with HyProCure®.

Global orthopedic medical device company marks their 9th year providing superior treatment options.

Extra-Osseous TaloTarsal Stabilization (EOTTS) Device gaining recognition across the globe with the latest addition of distribution in Italy.

Top Chinese surgeon travels to observe the HyProCure® procedure firsthand from leading U.S. foot and ankle surgeons.

Diminishing her dream of becoming a ballerina, Wanshop's flat feet caused chronic foot, hip and back pain for most of her life.

Global orthopedic medical device company, GraMedica®, supports podiatric students in their efforts to raise money to help the Yucatan Crippled Children’s Project.

Surgeon chooses the HyProCure® Extra-Osseous TaloTarsal Stabilization (EOTTS) procedure for teen soccer player wishing to get back in the game.

Surgeon chooses the HyProCure® Extra-Osseous TaloTarsal Stabilization (EOTTS) procedure as a solution to talotarsal displacement for his patients and for himself.

After 12 year old aspiring singer underwent the HyProCure® Extra-Osseous TaloTarsal Stabilization (EOTTS) procedure, she now has “normal looking feet” with no pain.

Surgeon believes in product and ease of performing Extra-Osseous TaloTarsal Stabilization (EOTTS) with HyProCure® enough to let his family member undergo the surgery.

Recent article published by the International Federation of Podiatrists uses evidenced based medicine to support claim regarding EOTTS with HyProCure®

With acceptance in the Chinese Market, GraMedica® gets closer to achieving goal of providing a real solution to patients suffering from misaligned feet globally.

HyProCure® Extra-Osseous TaloTarsal Stabilization (EOTTS) device offered as a superior treatment option to patients in China following the first HyProCure® procedures performed in the country.

Graham International Implant Institute's Symposium Provides Foot and Ankle Surgeons Information on Cutting-Edge Techniques and Bettering their Practice

GraMedica®, a global orthopedic medical device company, is proud to be a corporate sponsor of the American College of Foot and Ankle Pediatrics and to support their mission of education on the importance of caring for children’s feet.

Podiatric Success’s, Bret Ribotsky, DPM recently hosted Dr. Michael E. Graham, pioneer in Extra-Osseous TaloTarsal Stabilization and the inventor of HyProCure® on Meet the Masters.

Prestigious German Orthopedic Surgeon Recognizes GraMedica®’s Innovative Sinus Tarsi Implant as the Best Solution for the Correction of Flexible Flat Feet.

Evidence-based Analysis Proves Minimally Invasive Foot Implant by GraMedica® Offers Innovative Treatment Option with Significantly better Patient Outcomes than Similar Devices.

Top Chinese Foot Surgeon Invites HyProCure to His Clinic After Meeting the Creator of the Innovative Internal Extra-Osseous TaloTarsal Stabilization Device.

Surgeon with practice in Scottsdale, AZ, recognized for meeting the standards set by The Graham International Implant Institute in the use of the HyProCure® Internal, Extra-Osseous, Extra-Articular, TaloTarsal Fixation Device.

Surgeon from Bellmore, NY with vast experience using GraMedica®’s innovative sinus tarsi implant travels to Ecuador to educate and demonstrate the surgical procedure.

Largest Association of Chinese Orthopedists Selects Dr. Michael E. Graham and HyProCure® Research for Inclusion in Conference Agenda.